Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
A football fan who has stage four prostate cancer is backing a campaign for sanitary bins to be put in men's toilets at ...
Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...
Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...
Roughly one in every three men over the age of 65 in the UK face urinary incontinence, according to the Prostate Cancer UK charity An athlete and a former semi-pro footballer says he has been "put ...
WHEN was the last time you thought about your pelvic floor? Maybe never? If so, it’s time to start paying some attention as ...
Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...